AR066674A1 - Metodos para preparar una hirazida de hidracina y un cloruro de acilo, un compuesto que contiene un enlace de hidrazida, hidrazida de acido 3- metil-3 mercapto- butanoico y un inmunoconjugado de un miembro de la familia de las caliqueamicinas con un anticuerpo monoclonal como portador - Google Patents
Metodos para preparar una hirazida de hidracina y un cloruro de acilo, un compuesto que contiene un enlace de hidrazida, hidrazida de acido 3- metil-3 mercapto- butanoico y un inmunoconjugado de un miembro de la familia de las caliqueamicinas con un anticuerpo monoclonal como portadorInfo
- Publication number
- AR066674A1 AR066674A1 ARP080102165A ARP080102165A AR066674A1 AR 066674 A1 AR066674 A1 AR 066674A1 AR P080102165 A ARP080102165 A AR P080102165A AR P080102165 A ARP080102165 A AR P080102165A AR 066674 A1 AR066674 A1 AR 066674A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrazide
- prepare
- methyl
- immunocate
- hyrazac
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
- C07C323/48—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C241/00—Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C241/04—Preparation of hydrazides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/28—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
- C07C319/12—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by reactions not involving the formation of mercapto groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coating Apparatus (AREA)
Abstract
Un método para preparar hidrazidas a partir de hidrazina y un cloruro de acilo que comprende las etapas de: (a) preparar una suspension sustancialmente agitada y un disolvente inerte a baja temperatura; y (b) agregar un cloruro de acilocontinuamente a dicha suspension. El método evita o limita la produccion de subproductos bis-hidrazida no deseados. El método se utiliza para preparar hidrazida de ácido 3-metil-3-mercaptobutanoico, una molécula utilizada para enlazar calicheamicinaa un anti-cuerpo monoclonal.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93952907P | 2007-05-22 | 2007-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR066674A1 true AR066674A1 (es) | 2009-09-02 |
Family
ID=39810161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080102165A AR066674A1 (es) | 2007-05-22 | 2008-05-22 | Metodos para preparar una hirazida de hidracina y un cloruro de acilo, un compuesto que contiene un enlace de hidrazida, hidrazida de acido 3- metil-3 mercapto- butanoico y un inmunoconjugado de un miembro de la familia de las caliqueamicinas con un anticuerpo monoclonal como portador |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US8110705B2 (es) |
| EP (2) | EP2155258B1 (es) |
| JP (4) | JP5697446B2 (es) |
| KR (1) | KR101547705B1 (es) |
| CN (2) | CN102558001B (es) |
| AR (1) | AR066674A1 (es) |
| AU (1) | AU2008256905B2 (es) |
| BR (1) | BRPI0811140B1 (es) |
| CA (1) | CA2687852A1 (es) |
| CL (1) | CL2008001490A1 (es) |
| CY (2) | CY1119373T1 (es) |
| DK (2) | DK2465541T3 (es) |
| ES (2) | ES2686019T3 (es) |
| HK (2) | HK1147736A1 (es) |
| HU (2) | HUE039657T2 (es) |
| IL (1) | IL202242A (es) |
| MX (1) | MX2009012587A (es) |
| PA (1) | PA8781201A1 (es) |
| PE (1) | PE20090305A1 (es) |
| PL (2) | PL2465541T3 (es) |
| PT (2) | PT2155258T (es) |
| SI (2) | SI2155258T1 (es) |
| TW (1) | TW200904784A (es) |
| WO (1) | WO2008147765A1 (es) |
| ZA (1) | ZA200908229B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2155258T1 (sl) * | 2007-05-22 | 2017-10-30 | Wyeth Llc | Izboljšani postopki za izdelavo hidrazidov |
| JP6494240B2 (ja) | 2013-11-04 | 2019-04-03 | ファイザー・インク | カリケアマイシン誘導体を合成するための中間体および方法 |
| CN105828841A (zh) | 2013-11-04 | 2016-08-03 | 辉瑞大药厂 | 抗-efna4抗体-药物缀合物 |
| HUE053287T2 (hu) | 2014-04-30 | 2021-06-28 | Pfizer | PTK-7 elleni ellenanyag-drog konjugátumok |
| US10135670B2 (en) * | 2014-12-22 | 2018-11-20 | Hewlett Packard Enterprise Development Lp | Response to an inoperative network device managed by a controller |
| US20190048073A1 (en) | 2017-07-20 | 2019-02-14 | Pfizer Inc. | Anti-gd3 antibodies and antibody-drug conjugates |
| US20200318053A1 (en) | 2017-10-03 | 2020-10-08 | University Public Corporation Osaka | Cell culture container, method for acquiring cells, and method for culturing cells |
| CN109574870A (zh) * | 2018-12-25 | 2019-04-05 | 维思普新材料（苏州）有限公司 | 一种酰肼的连续制备方法 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US623230A (en) * | 1899-04-18 | Rotary ore-cooler | ||
| US4291022A (en) | 1975-03-11 | 1981-09-22 | Sandoz Ltd. | Organic compounds |
| DE2608336A1 (de) | 1975-03-11 | 1976-09-30 | Sandoz Ag | Neue organische verbindungen, ihre herstellung und verwendung |
| US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US4479953A (en) | 1983-08-25 | 1984-10-30 | Merck & Co., Inc. | Pyrazine aldimine compounds as antimicrobial agents |
| US4970198A (en) | 1985-10-17 | 1990-11-13 | American Cyanamid Company | Antitumor antibiotics (LL-E33288 complex) |
| HUT48093A (en) | 1986-08-04 | 1989-05-29 | Sandoz Ag | Herbicides comprising benzohydroxamic acid or benzoic acid hydrazide derivatives as active ingredient and process for producing benzohydroxamic acid or benzoic acid hydrazide derivatives |
| US4729781A (en) | 1986-08-04 | 1988-03-08 | Sandoz Ltd. | 3,6-dichloro-2-methoxybenzohydroxamic acid derivatives and use as herbicidal agents |
| US5079233A (en) | 1987-01-30 | 1992-01-07 | American Cyanamid Company | N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same |
| US4939244A (en) | 1987-01-30 | 1990-07-03 | American Cyanamid Company | Pseudoaglycones of LL-E33288 antibiotics |
| US5770701A (en) | 1987-10-30 | 1998-06-23 | American Cyanamid Company | Process for preparing targeted forms of methyltrithio antitumor agents |
| US5053394A (en) * | 1988-09-21 | 1991-10-01 | American Cyanamid Company | Targeted forms of methyltrithio antitumor agents |
| JPH05222044A (ja) * | 1991-10-25 | 1993-08-31 | Eastman Kodak Co | ２当量ピラゾロトリアゾールマゼンタカプラーの製造 |
| KR100235246B1 (ko) * | 1991-11-22 | 1999-12-15 | 아이.제이.크라코워 | 살충제 페닐히드라진 유도체 |
| US5690904A (en) * | 1993-07-12 | 1997-11-25 | Amersham International Plc | Diagnostic radiopharmaceutical compounds (That) |
| US5443953A (en) | 1993-12-08 | 1995-08-22 | Immunomedics, Inc. | Preparation and use of immunoconjugates |
| US5403015A (en) * | 1993-12-09 | 1995-04-04 | Forte; Steven L. | Cards and methods for playing casino 21 or blackjack |
| WO1996006096A1 (fr) | 1994-08-23 | 1996-02-29 | Nissan Chemical Industries, Ltd. | Derive de pyridine |
| IT1292092B1 (it) | 1997-06-05 | 1999-01-25 | Geange Ltd | Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali |
| EP1121361B1 (en) | 1998-10-16 | 2007-08-29 | Merck Sharp & Dohme Limited | Pyrazolo-triazine derivatives as ligands for gaba receptors |
| GB0008696D0 (en) | 2000-04-07 | 2000-05-31 | Merck Sharp & Dohme | Therapeutic agents |
| WO2002100826A2 (en) | 2001-06-08 | 2002-12-19 | Cytovia, Inc. | Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs |
| PL224001B1 (pl) * | 2002-05-02 | 2016-11-30 | Wyeth Corp | Sposób wytwarzania stabilnej liofilizowanej kompozycji obejmującej monomeryczne koniugaty pochodna kalicheamycyny/przeciwciało anty-CD22, kompozycja otrzymana tym sposobem oraz jej zastosowanie |
| US6803379B2 (en) | 2002-06-04 | 2004-10-12 | Jose A. Fernandez-Pol | Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets |
| WO2004058253A1 (en) | 2002-12-18 | 2004-07-15 | Cytovia, Inc. | 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| ATE441417T1 (de) | 2002-12-20 | 2009-09-15 | Glaxo Group Ltd | Benzoädüazepinderivate für die behandlung von neurologischen krankheiten |
| US7304161B2 (en) | 2003-02-10 | 2007-12-04 | Intrexon Corporation | Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| EP1622615A4 (en) * | 2003-05-13 | 2009-02-18 | Smithkline Beecham Corp | INHIBITORS OF THE INTEGRASE OF NAPHTHYRIDINE |
| WO2005005378A2 (en) | 2003-07-02 | 2005-01-20 | Sugen, Inc. | Indolinone hydrazides as c-met inhibitors |
| AR045010A1 (es) | 2003-07-02 | 2005-10-12 | Vertex Pharma | Pirimidinas utiles como moduladores de canales ionicos cuya activacion es controlada por tension |
| SE0302486D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| JP2007532552A (ja) * | 2004-04-06 | 2007-11-15 | セマフォア ファーマシューティカルズ， インコーポレイテッド | Ｐｔｅｎインヒビター |
| TW200630106A (en) * | 2004-10-08 | 2006-09-01 | Wyeth Corp | Immunotherapy of autoimmune disorders |
| TWI404706B (zh) * | 2006-01-11 | 2013-08-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
| SI2155258T1 (sl) * | 2007-05-22 | 2017-10-30 | Wyeth Llc | Izboljšani postopki za izdelavo hidrazidov |
-
2008
- 2008-05-20 SI SI200831859T patent/SI2155258T1/sl unknown
- 2008-05-20 MX MX2009012587A patent/MX2009012587A/es active IP Right Grant
- 2008-05-20 ES ES12159159.8T patent/ES2686019T3/es active Active
- 2008-05-20 CN CN201110434577.XA patent/CN102558001B/zh active Active
- 2008-05-20 PT PT87559456T patent/PT2155258T/pt unknown
- 2008-05-20 AU AU2008256905A patent/AU2008256905B2/en active Active
- 2008-05-20 SI SI200831994T patent/SI2465541T1/sl unknown
- 2008-05-20 CN CN2008800216526A patent/CN101835494B/zh active Active
- 2008-05-20 ES ES08755945.6T patent/ES2642888T3/es active Active
- 2008-05-20 JP JP2010509499A patent/JP5697446B2/ja active Active
- 2008-05-20 PL PL12159159T patent/PL2465541T3/pl unknown
- 2008-05-20 US US12/123,777 patent/US8110705B2/en active Active
- 2008-05-20 HU HUE12159159A patent/HUE039657T2/hu unknown
- 2008-05-20 CA CA2687852A patent/CA2687852A1/en not_active Abandoned
- 2008-05-20 EP EP08755945.6A patent/EP2155258B1/en active Active
- 2008-05-20 BR BRPI0811140-5A patent/BRPI0811140B1/pt active IP Right Grant
- 2008-05-20 EP EP12159159.8A patent/EP2465541B1/en active Active
- 2008-05-20 KR KR1020097026806A patent/KR101547705B1/ko active Protection Beyond IP Right Term
- 2008-05-20 DK DK12159159.8T patent/DK2465541T3/en active
- 2008-05-20 PL PL08755945T patent/PL2155258T3/pl unknown
- 2008-05-20 PT PT12159159T patent/PT2465541T/pt unknown
- 2008-05-20 WO PCT/US2008/064213 patent/WO2008147765A1/en active Application Filing
- 2008-05-20 DK DK08755945.6T patent/DK2155258T3/en active
- 2008-05-20 HU HUE08755945A patent/HUE036704T2/hu unknown
- 2008-05-20 PE PE2008000869A patent/PE20090305A1/es not_active Application Discontinuation
- 2008-05-22 PA PA20088781201A patent/PA8781201A1/es unknown
- 2008-05-22 TW TW097118930A patent/TW200904784A/zh unknown
- 2008-05-22 AR ARP080102165A patent/AR066674A1/es unknown
- 2008-05-22 CL CL200801490A patent/CL2008001490A1/es unknown
-
2009
- 2009-11-19 IL IL202242A patent/IL202242A/en active IP Right Grant
- 2009-11-20 ZA ZA200908229A patent/ZA200908229B/xx unknown
-
2011
- 2011-02-23 HK HK11101744.4A patent/HK1147736A1/xx unknown
-
2012
- 2012-01-27 US US13/360,220 patent/US8383857B2/en active Active
- 2012-12-11 HK HK12112795.8A patent/HK1172008A1/zh unknown
-
2013
- 2013-01-31 US US13/755,886 patent/US8853451B2/en active Active
- 2013-08-23 JP JP2013172956A patent/JP2013234203A/ja not_active Withdrawn
-
2014
- 2014-10-02 US US14/504,738 patent/US9227924B2/en active Active
-
2015
- 2015-11-06 JP JP2015218118A patent/JP2016026219A/ja not_active Withdrawn
- 2015-12-18 US US14/973,869 patent/US9738602B2/en active Active
-
2017
- 2017-08-03 JP JP2017150482A patent/JP2017193584A/ja active Pending
- 2017-09-20 CY CY20171100991T patent/CY1119373T1/el unknown
-
2018
- 2018-08-13 CY CY181100854T patent/CY1120592T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR066674A1 (es) | Metodos para preparar una hirazida de hidracina y un cloruro de acilo, un compuesto que contiene un enlace de hidrazida, hidrazida de acido 3- metil-3 mercapto- butanoico y un inmunoconjugado de un miembro de la familia de las caliqueamicinas con un anticuerpo monoclonal como portador | |
| Sun et al. | Lithium bromide as a mild, efficient, and recyclable catalyst for the one-pot synthesis of tetrahydro-4 H-chromene derivatives in aqueous media | |
| EA200801697A1 (ru) | Способ выделения органического амина | |
| Balalaie et al. | Novel, efficient, and green procedure for the Knoevenagel condensation catalyzed by diammonium hydrogen phosphate in water | |
| EA201291470A1 (ru) | Замороженное кондитерское изделие | |
| MX2013013144A (es) | Metodo para la produccion de un dimero mdi. | |
| PE20120663A1 (es) | Anticuerpos anti-htnf alfa cristalinos | |
| WO2012024368A3 (en) | Method of synthesis of substituted hexitols such as dianhydrogalactitol | |
| CL2007002989A1 (es) | Anticuerpos anti-notch3; acido nucleico que los codifica; vector y celula que lo comprende; metodo de produccion; y su uso para el diagnostico de enfermedades relacionadas con notch3. | |
| EA200901175A1 (ru) | Способ получения 2,6-дихлор-4-(трифторметил)фенилгидразина, используя смеси дихлор-фтор-трифторметилбензолов | |
| Guo | Base mediated direct C–H amination for pyrimidines synthesis from amidines and cinnamaldehydes using oxygen as green oxidants | |
| Liu et al. | Dimeric trigger factor stably binds folding-competent intermediates and cooperates with the DnaK-DnaJ-GrpE chaperone system to allow refolding | |
| Aerry et al. | Chemoselective acetylation of amines and thiols using monodispersed Ni-nanoparticles | |
| BR112013021671A2 (pt) | processo para a preparação de um campo de poliéster hiper-ramificado da invenção | |
| BR112017013025A2 (pt) | recuperação de óleo da lama de palma | |
| Khan et al. | New three-component condensation reaction: synthesis of 1-[(alkylthio)(phenyl) methyl]-naphthalene-2-ol catalyzed by bromodimethylsulfonium bromide (BDMS) | |
| Wet-Osot et al. | Facile synthesis of N-acylbenzotriazoles from carboxylic acids mediated by 2, 4, 6-trichloro-1, 3, 5-triazine and triethylamine | |
| BR112014027994A2 (pt) | métodos de cristalização para purificação de anticorpos monoclonais | |
| BR112012014347A2 (pt) | processo de epoxidação e microestrutura | |
| Pati et al. | Ag (i)-catalyzed carbon–carbon bond formation between a ketone and an allylic C–H bond | |
| WO2006129120A3 (en) | Benzotriazepinone derivatives | |
| Huang et al. | Recent theoretical researches on transportation safety planning | |
| CN106831765A (zh) | 2‑(2,6‑二氰基苯基)咪唑并[1,2‑α]吡啶类化合物及其制备方法 | |
| Abdel-Hafez et al. | Synthesis and cytotoxicity evaluation of some new pyrimidinethione and thiazolopyrimidine derivatives linked to N-propylpiperidone | |
| AR119546A1 (es) | Métodos para purificar anticuerpos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |